| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/14/2004 | EP1379253A1 Methods of making and pharmaceutical formulations comprising 7alpha,11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 01/14/2004 | EP1379249A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 01/14/2004 | EP1379241A1 Compounds and methods |
| 01/14/2004 | EP1379240A1 Compounds and methods |
| 01/14/2004 | EP1379234A1 Halogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf |
| 01/14/2004 | EP1379233A1 Use of a substantially cell membrane impermeable compound for treating arthritis |
| 01/14/2004 | EP1379230A1 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| 01/14/2004 | EP1379139A2 The use of ecm degrading enzymes for the improvement of cell transplantation |
| 01/14/2004 | EP1379135A1 Formulations comprising entrapped active ingredients and uses thereof |
| 01/14/2004 | EP1379125A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 01/14/2004 | EP1222195B1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 01/14/2004 | EP1112265B1 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 01/14/2004 | CN1468305A Modulation of the transcription of pro-inflammatory gene products |
| 01/14/2004 | CN1468246A Hydroxyesters of 7-desmethylrapamycin |
| 01/14/2004 | CN1468239A Substituted pyrazoles |
| 01/14/2004 | CN1468238A Substituted pyrazoles |
| 01/14/2004 | CN1468232A Heterocyclic sodium/proton exchange inhibitors and method |
| 01/14/2004 | CN1468228A 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 01/14/2004 | CN1468226A Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 01/14/2004 | CN1468219A Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1468209A Stable salts of o-acetylsalicyclic with basic amino acids |
| 01/14/2004 | CN1468108A Bone health compositions derived from milk |
| 01/14/2004 | CN1467222A Human interleukin-17 receptor sampling molecule fusion protein and coding gene and expression cell line |
| 01/14/2004 | CN1466989A Oral liquid for treating protrasion of the lumbar intervertebral disci |
| 01/14/2004 | CN1466976A Medicine for preventing and curing rachitis and osteoporosis and method for preparing the same |
| 01/14/2004 | CN1466956A Bolus for resisting osteoproliferation |
| 01/14/2004 | CN1134537C Preparation of human primitive mesenchymal stem cell population |
| 01/14/2004 | CN1134452C Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 01/14/2004 | CN1134423C Adhesion receptor antagonists |
| 01/14/2004 | CN1134420C Novel substituted imidazole compounds |
| 01/14/2004 | CN1134418C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation |
| 01/13/2004 | US6677376 Complexes comprising rotamase inhibitors and cyclophilins, administered for prevention of neurodegenarative diseases such as parkinson's or alzheimer's disease |
| 01/13/2004 | US6677373 Polymorphic B form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5H-furan-2-one |
| 01/13/2004 | US6677368 4-aryl substituted indolinones |
| 01/13/2004 | US6677365 Antagonists of MCP-1 function and methods of use thereof |
| 01/13/2004 | US6677355 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 01/13/2004 | US6677351 Useful in treatment of asthma and inflammation |
| 01/13/2004 | US6677340 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/13/2004 | US6677339 S-3-(4-(3,5-dichloropyrid-4-ylcarboxamido)phenyl)-2-(4,6-dimet hoxy-1,3,5-triazin-2-ylamino)propanoic acid for example; inhibit binding of alpha 4 integrins to their ligands, for treating immune or inflammatory disorders |
| 01/13/2004 | US6677329 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 01/13/2004 | US6677320 Mixture with chelate compound; bone disorders |
| 01/13/2004 | US6677298 Protein antagonist; antidiabetic agents, antilipemic agents |
| 01/13/2004 | US6676970 Subcutaneous osteoporosis compositions |
| 01/13/2004 | US6676939 Methods of modulating IL-174 response |
| 01/08/2004 | WO2004003235A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | WO2004003164A2 Methods of organ regeneration |
| 01/08/2004 | WO2004003007A1 Non-t cell binding peptides and their uses |
| 01/08/2004 | WO2004002961A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | WO2004002960A1 Substituted quinoline ccr5 receptor antagonists |
| 01/08/2004 | WO2004002533A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | WO2004002525A1 Use of antibodies against flt-1 for the treatment of osteoporosis |
| 01/08/2004 | WO2004002524A1 Placental growth factor as a target for the treatment of osteoporosis |
| 01/08/2004 | WO2004002505A1 Compositions against inflammatory processes |
| 01/08/2004 | WO2004002496A1 Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation |
| 01/08/2004 | WO2004002484A1 Phosphodiesterase inhibitor |
| 01/08/2004 | WO2004002455A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 01/08/2004 | WO2004002424A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002420A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | WO2003090912A9 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/08/2004 | WO2003087174A3 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/08/2004 | WO2003087088A3 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them |
| 01/08/2004 | WO2003086315A3 Tyrosine kinase inhibitors |
| 01/08/2004 | WO2003070166A3 Novel tyloindicines and related processes, pharmaceutical compositions and methods |
| 01/08/2004 | WO2003068812A3 Immune-modulating peptide made of s. aureus enterotoxin b |
| 01/08/2004 | WO2003047618A3 Immunotherapeutic methods and systems |
| 01/08/2004 | WO2003007923A3 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases |
| 01/08/2004 | WO2002095067A3 INTERFERON α-14 POLYMORPHISM |
| 01/08/2004 | WO2002092623A8 INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF |
| 01/08/2004 | WO2002083065A3 Peptide antiangiogenic drugs |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | WO2002068650B1 Modified and stabilized gdf propeptides and uses thereof |
| 01/08/2004 | WO2002053522A3 Novel estrogen receptor ligands and methods i |
| 01/08/2004 | WO2002046225A3 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 01/08/2004 | US20040006245 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain |
| 01/08/2004 | US20040006242 Immunomodulatory compounds and method of use thereof |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006208 Comprises three-dimensional structure of bound immunoglobulin complex; antiinflammatory/anticarcinogenic; viricides |
| 01/08/2004 | US20040006207 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 01/08/2004 | US20040006133 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | US20040006105 Thrombin receptor antagonists |
| 01/08/2004 | US20040006096 Substituted alkanohydroxamic acids and method of reducing TNFalpha levels |
| 01/08/2004 | US20040006095 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 01/08/2004 | US20040006089 For therapy of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome |
| 01/08/2004 | US20040006083 Pyrazolopyrimidines as therapeutic agents |
| 01/08/2004 | US20040006082 For therapy and prophylaxis of diabetes, diabetic complications, diabetic retinopathy, obesity or asthma, hypoglycemic agent, an improving agent for impaired glucose tolerance, a potentiating agent for insulin sensitivity |
| 01/08/2004 | US20040006081 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 01/08/2004 | US20040006080 Chemical compounds |
| 01/08/2004 | US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease |
| 01/08/2004 | US20040006075 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 01/08/2004 | US20040006067 Substituted piperidines and methods of use |
| 01/08/2004 | US20040006066 Ring fused pyrazole derivatives as CRF antagonists |
| 01/08/2004 | US20040006063 Dipeptide derivatives |
| 01/08/2004 | US20040006057 For therapy of connective tissue disorders, inflammatory disorders, immunology/allergy disorders, infectious diseases, respiratory diseases, cardiovascular diseases, eye diseases, metabolic diseases, central nervous system (CNS) disorders |
| 01/08/2004 | US20040006022 For therapy of autoimmune or an inflammatory disease |
| 01/08/2004 | US20040006003 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 01/08/2004 | US20040005689 Three dimensional model of acute myeloid leukemia protein (AML-1) comprising runt domain for treating and preventing diseases associated with chromosomal translocations; genetic mapping |
| 01/08/2004 | US20040005630 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 01/08/2004 | US20040005629 Natural ligand of orphan G protein coupled receptor GPR86 and methods of use |
| 01/08/2004 | US20040005619 Diagnosing osteoporosis and paget's diseases via identifying variable numbers of tandem repeats in allelic sequences coding parathyroid hormone related peptide (PTHrP) |